G
G.I. Windows
Non-surgical treatment of type-2 diabetes and obesity, by creating endo-luminal anastomoses that bypass portions of the GI tract
About G.I. Windows
GI Windows Surgical is pioneering a groundbreaking anastomotic technology that facilitates less invasive surgical procedures, addressing a significant global need for patients with obesity, Type 2 diabetes, and those undergoing colorectal surgery. The company operates in the medical technology sector, focusing on developing solutions that improve patient outcomes, reduce healthcare costs, and enhance the efficiency of care delivery. GI Windows Surgical's core product leverages magnetic compression anastomosis, which allows for the creation of a wide, permanent anastomosis using a common flexible endoscope in a minimally invasive manner. This innovative approach has the potential to transform digestive surgery practices, offering a simpler and more effective alternative to traditional methods. The company's business model involves the development and commercialization of this technology, targeting healthcare providers and institutions that perform surgical procedures. Revenue is generated through the sale of their proprietary devices and related services. The market for GI Windows Surgical's technology includes hospitals, surgical centers, and clinics that specialize in gastrointestinal and metabolic surgeries. The company is led by a team of experienced professionals with a proven track record in bringing disruptive medical technologies to market.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2012
- Headquarters
- West Bridgewater, United States
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 90.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Personal Health, Diabetes, Biotechnology, Weight Management, Spinout, Metabolism, Biotech and Pharma, DT and LS, science-based
- Client focus
- b2c
Latest news
Press, funding announcements and product moves mentioning G.I. Windows.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Dec 2024 | $43M | $172M | Johnson & Johnson · Rex Health Ventures · Orlando Health Ventures | ↗ |
| EARLY VCOther financing | Jun 2022 | $14M | $82M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for G.I. Windows is 1.9K monthly website visits, up 245.5% over the last three months. G.I. Windows's team grew 19.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A8 investors entered at this stage
Broadview Ventures
GT Healthcare
Sonder Capital
Johnson & Johnson Innovation
Kennedy Trust
Orlando Health Ventures
Johnson & Johnson
Rex Health Ventures
Other known investors3 additional known investors
Brigham and Women's Hospital
Harvard Medical School
Massachusetts Institute of Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about G.I. Windows on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See G.I. Windows’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







